Annual decline in estimated glomerular filtration rate is a risk factor for cardiovascular events independent of proteinuria

Nephrology

Volumn 19, Issue 9, 2014, Pages 574-580

  Nagai, Kei ^a   Yamagata, Kunihiro ^a,b   Ohkubo, Reiko ^a   Saito, Chie ^a   Asahi, Koichi ^b   Iseki, Kunitoshi ^b   Kimura, Kenjiro ^b   Moriyama, Toshiki ^b   Narita, Ichiei ^b   Fujimoto, Shouichi ^b   Tsuruya, Kazuhiko ^b   Konta, Tsuneo ^b   Kondo, Masahide ^b   Watanabe, Tsuyoshi ^b  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b Steering Committee for Design of the Comprehensive Health Care System for Chronic Kidney Disease Specific Health Checkups   (Japan)

Author keywords

cardiovascular diseases; chronic kidney diseases; glomerular filtration rate; proteinuria; risk factor

Indexed keywords

CREATININE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CREATININE BLOOD LEVEL; DISEASE COURSE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; INCIDENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEINURIA; CARDIOVASCULAR DISEASES; JAPAN; KIDNEY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR; TIME;

ADULT; AGED; CARDIOVASCULAR DISEASES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; JAPAN; KIDNEY; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; PROTEINURIA; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; TIME FACTORS;

EID: 84906698809     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/nep.12286     Document Type: Article

References (25)

1. Anavekar NS, McMurray JJ, Velazquez EJ, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N. Engl. J. Med. 2004; 351: 1285-1295.
2. Weiner DE, Tighiouart H, Amin MG, et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: A pooled analysis of community-based studies. J. Am. Soc. Med. 2004; 15: 1307-1315.
3. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY,. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 2004; 351: 1296-1305.
4. Muntner P, He J, Hamm L, Loria C, Whelton PK,. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J. Am. Soc. Med. 2002; 13: 745-753.
5. Manjunath G, Tighiouart H, Ibrahim H, et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J. Am. Coll. Cardiol. 2003; 41: 47-55.
6. Irie F, Iso H, Sairenchi T, et al. The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population. Kidney Int. 2006; 69: 1264-1271.
7. Ninomiya T, Kiyohara Y, Kubo M, et al. Chronic kidney disease and cardiovascular disease in a general Japanese population: The Hisayama Study. Kidney Int. 2005; 68: 228-236.
8. Turin TC, Coresh J, Tonelli M, et al. Change in the estimated glomerular filtration rate over time and risk of all-cause mortality. Kidney Int. 2013; 83: 684-691.
9. Rifkin DE, Shlipak MG, Katz R, et al. Rapid kidney function decline and mortality risk in older adults. Arch. Intern. Med. 2008; 168: 2212-2218.
10. Perkins RM, Bucaloiu ID, Kirchner HL, Ashouian N, Hartle JE, Yahya T,. GFR decline and mortality risk among patients with chronic kidney disease. Clin. J. Am. Soc. Nephrol. 2011; 6: 1879-1886.
11. Matsushita K, Selvin E, Bash LD, Franceschini N, Astor BC, Coresh J,. Change in estimated GFR associates with coronary heart disease and mortality. J. Am. Soc. Nephrol. 2009; 20: 2617-2624.
12. Cheng TY, Wen SF, Astor BC, Tao XG, Samet JM, Wen CP,. Mortality risks for all causes and cardiovascular diseases and reduced GFR in a middle-aged working population in Taiwan. Am. J. Kidney Dis. 2008; 52: 1051-1060.
13. Al-Aly Z, Zeringue A, Fu J, et al. Rate of kidney function decline associates with mortality. J. Am. Soc. Nephrol. 2010; 21: 1961-1969.
14. Shlipak MG, Katz R, Kestenbaum B, et al. Rapid decline of kidney function increases cardiovascular risk in the elderly. J. Am. Soc. Nephrol. 2009; 20: 2625-2630.
15. Levey AS, de Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: A KDIGO Controversies Conference report. Kidney Int. 2011; 80: 17-28.
16. Yano Y, Sato Y, Fujimoto S, et al. Association of high pulse pressure with proteinuria in subjects with diabetes, prediabetes, or normal glucose tolerance in a large Japanese general population sample. Diabetes Care 2012; 35: 1310-1315.
17. Sato Y, Yano Y, Fujimoto S, et al. Glycohemoglobin not as predictive as fasting glucose as a measure of prediabetes in predicting proteinuria. Nephrol. Dial. Transplant. 2012; 27: 3862-3868.
18. Konta T, Hao Z, Takasaki S, et al. Clinical utility of trace proteinuria for microalbuminuria screening in the general population. Clin. Exp. Nephrol. 2007; 11: 51-55.
19. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D,. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann. Intern. Med. 1999; 130: 461-470.
20. Guidelines Subcommittee. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J. Hypertens. 1999; 17: 151-183.
21. Kim-Mitsuyama S, Ogawa H, Matsui K, Jinnouchi T, Jinnouchi H, Arakawa K,. An angiotensin II receptor blocker-calcium channel blocker combination prevents cardiovascular events in elderly high-risk hypertensive patients with chronic kidney disease better than high-dose angiotensin II receptor blockade alone. Kidney Int. 2013; 83: 167-176.
22. Kovesdy CP, George SM, Anderson JE, Kalantar-Zadeh K,. Outcome predictability of biomarkers of protein-energy wasting and inflammation in moderate and advanced chronic kidney disease. Am. J. Clin. Nutr. 2009; 90: 407-414.
23. Agarwal AHN, Haddad N, Hebert LA,. Progression of kidney disease: Diagonsis and management. In:, Molony D, Craig J, (eds). Evidence-Based Nephrology. Hoboken, NJ: Weily, 2008; 311-322.
24. Nagai K, Saito C, Watanabe F, et al. Annual incidence of persistent proteinuria in the general population from Ibaraki annual urinalysis study. Clin. Exp. Nephrol. 2013; 17: 255-260.
25. Kondo M, Yamagata K, Hoshi SL, et al. Cost-effectiveness of chronic kidney disease mass screening test in Japan. Clin. Exp. Nephrol. 2012; 16: 279-291.